Springbok Capital Management »

4d Molecular Therapeutics In shares owned by Springbok Capital Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $200k 23k 8.69
2025-06-30 $77k 21k 3.71
2025-03-31 $73k 23k 3.23
2022-12-31 $281k 13k 22.21